Frontlight ResearchEarly access
What researchers published on Ovarian cancer
43,193 papers, newest first.
Showing 40 of 43,193
Case reportFamilial Ovarian Teratoma With Neural Tissue Expression and Anti-NMDAR Encephalitis.Neurology(R) neuroimmunology & neuroinflammation
Matrix Softness and Fluid Shear Force Act Through TRPV4 to Promote Ovarian Cancer Stemness.Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ReviewTumor-associated macrophages in ovarian, prostate, thyroid and pancreatic neuroendocrine tumors: molecular crosstalk and therapeutic perspectives.Molecular biology reports
Generation of mixed ovarian cancer and fibroblast spheroids by bioprinting.In vitro models
Cross-database thromboembolic reporting signals for ovarian cancer therapies: a focus on bevacizumab.BMC cancer
[Emphasis on the standardization of initial treatment for ovarian cancer].Zhonghua yi xue za zhi
ReviewAdvances in Biomarker Discovery for Early Ovarian Cancer Diagnosis.Cells
Diagnostic Performance of Contrast-Enhanced Computed Tomography in Predicting Lymph Node Metastasis in Epithelial Ovarian Cancer: The Added Value of Combining CT with CA-125.Diagnostics (Basel, Switzerland)
Infrared Treatment Alters the Chemical Profile and In Vitro Bioactivity of Jojoba Oil: Antimicrobial, Biofilm Formation Inhibition and Ovarian Cancer Cell Responses.International journal of molecular sciences
FABP4 is associated with ROS-dependent ferroptosis inhibition and platinum resistance in ovarian cancer.Tissue & cell
ReviewImmune Resistance and Anti-Tumor Immunity in the Ovarian Tumor Microenvironment.Cells
PADI2 facilitates progression and cisplatin resistance of epithelial ovarian cancer via m6A methylation.iScience
Biologic and immunologic characteristics of ovarian cancers that are associated with p53 autoantibodies.Cancer
ReviewPrognostic Value of the KELIM Score Versus Conventional CA-125 Kinetics in Ovarian Cancer: A Systematic Review and Meta-Analysis.Diagnostics (Basel, Switzerland)
Comparison of Sonidegib and Vismodegib Efficiency in Drug-Sensitive and Resistant Ovarian Cancer Cell Lines-2D and 3D Model Study.International journal of molecular sciences
ReviewThe Role of D-3-Phosphoglycerate Dehydrogenase (PHGDH) in Chemoresistance in Ovarian Cancer: Molecular Insights and Therapeutic Potential.International journal of molecular sciences
Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer.International journal of molecular sciences
A leakage-aware and interpretable machine learning framework for ovarian cancer prediction using the PLCO screening dataset.Frontiers in oncology
Hypoxia-Associated Glycolytic-Lipogenic Reprogramming and Impaired Antigen Presentation in SPP1+ Tumor-Associated Macrophages in Ovarian Cancer.International journal of molecular sciences
Correction: Gralewska-Zając et al. Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer. Int. J. Mol. Sci. 2026, 27, 2630.International journal of molecular sciences
ReviewFolate Receptor Alpha (FRα/FOLR1) in Cancer: Diagnostic, Prognostic or Predictive Biomarker? A Critical Review of Its Clinical Utility.International journal of molecular sciences
Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study.Cancers
ReviewExtracellular Vesicle-Associated Epithelial-Mesenchymal Plasticity (EMP) as a Driver of Metastatic Evolution and Therapeutic Resistance in Ovarian Cancer.Cancers
Platelet-Derived Extracellular Vesicles for the Diagnosis of Ovarian Cancer.Cancers
"Hearing the Ovarian Cancer Whisper": A Pipeline Program Introducing Medical Students to Gynecologic Oncology, Focusing on the Diagnosis and Management of Ovarian Cancer.Medical science educator
Minimally invasive surgery improves surgical and analgesic outcomes in overweight or obese patients with borderline ovarian tumors: A retrospective cohort study.Medicine
Compartment-Resolved Profiling Identifies Shared Stromal Programs and Clarifies Molecular Subtype Origins in Ovarian Cancer.Cancer research
ReviewCellular senescence in ovarian cancer: context-dependent effects on tumor immunity and therapy response.Frontiers in immunology
Risk Factor Profiles May Differ Between Younger-Onset and Late-Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort.Asia-Pacific journal of clinical oncology
Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer.Cell systems
Clinical characteristics and treatment strategies of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis based on a case series.Frontiers in neurology
Tuberculous Salpingo-Oophoritis Mimicking Ovarian Malignancy: A Case Report of a Diagnostic Dilemma.Clinical case reports
MRPL47 as a mitochondrial biomarker for early detection and therapeutic response in ovarian cancer.Molecular therapy. Oncology
Surgical opportunities for primary prevention of high-grade serous ovarian cancer: a procedure-level analysis of opportunistic salpingectomy.Journal of ovarian research
Perillaldehyde (PAE) Regulates Ovarian Cancer by Modulating HSP70 and Regulating the PI3K/AKT Signaling Pathway.Archives of biochemistry and biophysics
Trial resultPamiparib plus surufatinib with ctDNA monitoring in platinum-resistant ovarian cancer after PARP inhibitor progression: a phase Ib/II trial (POST-PARPi).BMC medicine
AIF promotes ovarian cancer progression by competitively binding TRAP1 to stabilize MtCK1 to drive phosphocreatine synthesis.Journal of translational medicine
Fertility-sparing surgery for early-stage epithelial ovarian cancer: evolving criteria for patient selection.Japanese journal of clinical oncology
Randomised trialFuzuloparib in combination with apatinib versus fuzuloparib alone for recurrent ovarian cancer: a randomized, open-label, phase 2 trial.Journal of ovarian research
PD-L1 expression in epithelial ovarian cancer and survival: a retrospective cohort study.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia